Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Neogen Corporation before investing.

In this article, we go over a few key elements for understanding Neogen Corporation’s stock price such as:

• Neogen Corporation’s current stock price and volume
• Why Neogen Corporation’s stock price changed recently
• Upgrades and downgrades for NEOG from analysts
• NEOG’s stock price momentum as measured by its relative strength

About Neogen Corporation (NEOG)

Before we jump into Neogen Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Want to learn more about Neogen Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Neogen Corporation.

Neogen Corporation’s Stock Price as of Market Close

As of August 21, 2026, 3:45 PM, CST, Neogen Corporation’s stock price was $11.880.

Neogen Corporation is up 0.42% from its previous closing price of $11.830.

During the last market session, Neogen Corporation’s stock traded between $11.682 and $11.950. Currently, there are approximately 217.70 million shares outstanding for Neogen Corporation.

Neogen Corporation’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

Neogen Corporation Stock Price History

Neogen Corporation’s (NEOG) price is currently down 1.33% so far this month.

During the month of August, Neogen Corporation’s stock price has reached a high of $12.850 and a low of $11.145.

Over the last year, Neogen Corporation has hit prices as high as $12.850 and as low as $4.900. Year to date, Neogen Corporation’s stock is up 69.96%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Neogen Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 20, 2026, there was 1 analyst who downgraded Neogen Corporation’s stock and 0 analysts who upgraded over the last month.

Additionally, you'll want to evaluate Neogen Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Neogen Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Neogen Corporation’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Neogen Corporation (NEOG) by visiting AAII Stock Evaluator.

Relative Price Strength of Neogen Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 20, 2026, Neogen Corporation has a weighted four-quarter relative price strength of 23.73%, which translates to a Momentum Score of 93 and is considered to be Very Strong.

Want to learn more about how Neogen Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Neogen Corporation Stock Price: Bottom Line

As of August 21, 2026, Neogen Corporation’s stock price is $11.880, which is up 0.42% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Neogen Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.